[Federal Register Volume 70, Number 2 (Tuesday, January 4, 2005)]
[Notices]
[Pages 392-393]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-70]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to 21 CFR 1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 4, 2004, Noramco 
Inc., Division of Ortho-McNeil, Inc., 500 Old Swedes Landing Road, 
Wilmington, Delaware 19801, made application by renewal and by letter 
to the Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of Dihydrocodeine (9120), a basic class of controlled 
substance listed in Schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative, 
Office

[[Page 393]]

of Liaison and Policy (ODLR) and must be filed no later than March 7, 
2005.

    Dated: December 21, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-70 Filed 1-3-05; 8:45 am]
BILLING CODE 4410-09-P